Is Daxor Stock a Good Investment?
Daxor Investment Advice | DXR |
- Examine Daxor's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Daxor's leadership team and their track record. Good management can help Daxor navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Daxor's business and its evolving consumer preferences.
- Compare Daxor's performance and market position to its competitors. Analyze how Daxor is positioned in terms of product offerings, innovation, and market share.
- Check if Daxor pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Daxor's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Daxor stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Daxor is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Daxor Stock
Researching Daxor's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 57.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.13. Some equities with similar Price to Book (P/B) outperform the market in the long run. Daxor recorded a loss per share of 0.09. The entity last dividend was issued on the 5th of January 2018.
To determine if Daxor is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Daxor's research are outlined below:
Daxor generated a negative expected return over the last 90 days | |
About 57.0% of the company shares are held by company insiders | |
Latest headline from news.google.com: Daxor Corporation Q4 2024 Earnings Call Transcript - MSN |
Daxor Target Price Consensus
Daxor target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Daxor's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
2 | Strong Buy |
Most Daxor analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Daxor stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Daxor, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationDaxor Target Price Projection
Daxor's current and average target prices are 7.97 and 23.38, respectively. The current price of Daxor is the price at which Daxor is currently trading. On the other hand, Daxor's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Daxor Target Price
Daxor Analyst Ratings
Daxor's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Daxor stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Daxor's financials, market performance, and future outlook by experienced professionals. Daxor's historical ratings below, therefore, can serve as a valuable tool for investors.Know Daxor's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Daxor is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Daxor backward and forwards among themselves. Daxor's institutional investor refers to the entity that pools money to purchase Daxor's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Vanguard Group Inc | 2024-12-31 | 48.8 K | Renaissance Technologies Corp | 2024-12-31 | 27.8 K | Keyes Stange & Wooten Wealth Management Llc | 2024-12-31 | 14.6 K | Advisor Group Holdings, Inc. | 2024-12-31 | 7.2 K | Sbi Securities Co Ltd | 2024-12-31 | 3.1 K | Ubs Group Ag | 2024-12-31 | 2.6 K | Princeton Global Asset Management Llc | 2024-12-31 | 500 | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 88.0 | Jpmorgan Chase & Co | 2024-12-31 | 5.0 | Wells Fargo & Co | 2024-12-31 | 0.0 | Jones Financial Companies Lllp | 2024-12-31 | 0.0 |
Daxor's market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 39.33 M.Market Cap |
|
Daxor's profitablity analysis
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.01 | 0.01 | |
Return On Capital Employed | (0.03) | (0.03) | |
Return On Assets | 0.01 | 0.01 | |
Return On Equity | 0.01 | 0.02 |
Determining Daxor's profitability involves analyzing its financial statements and using various financial metrics to determine if Daxor is a good buy. For example, gross profit margin measures Daxor's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Daxor's profitability and make more informed investment decisions.
Evaluate Daxor's management efficiency
Daxor has Return on Asset of (0.0251) % which means that on every $100 spent on assets, it lost $0.0251. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0154 %, implying that it generated $0.0154 on every 100 dollars invested. Daxor's management efficiency ratios could be used to measure how well Daxor manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/18/2025, Return On Equity is likely to grow to 0.02, while Return On Tangible Assets are likely to drop 0.01. At this time, Daxor's Total Assets are relatively stable compared to the past year. As of 03/18/2025, Non Current Assets Total is likely to grow to about 42.1 M, while Non Currrent Assets Other are likely to drop (38.4 M).Last Reported | Projected for Next Year | ||
Book Value Per Share | 7.39 | 4.97 | |
Tangible Book Value Per Share | 7.39 | 4.97 | |
Enterprise Value Over EBITDA | 123.41 | 129.58 | |
Price Book Value Ratio | 1.04 | 1.35 | |
Enterprise Value Multiple | 123.41 | 129.58 | |
Price Fair Value | 1.04 | 1.35 | |
Enterprise Value | 33.5 M | 37.2 M |
The management strategies employed by Daxor's are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Beta (0.53) |
Basic technical analysis of Daxor Stock
As of the 18th of March 2025, Daxor shows the Mean Deviation of 1.92, standard deviation of 2.41, and Variance of 5.81. Daxor technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Daxor market risk adjusted performance and treynor ratio to decide if Daxor is priced favorably, providing market reflects its regular price of 7.97 per share. Given that Daxor has information ratio of (0.01), we urge you to verify Daxor's prevailing market performance to make sure the company can sustain itself at a future point.Daxor's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Daxor insiders, such as employees or executives, is commonly permitted as long as it does not rely on Daxor's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Daxor insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Daxor's Outstanding Corporate Bonds
Daxor issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Daxor uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Daxor bonds can be classified according to their maturity, which is the date when Daxor has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Daxor's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Daxor's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
Risk Adjusted Performance | (0.04) | |||
Market Risk Adjusted Performance | (0.48) | |||
Mean Deviation | 1.92 | |||
Coefficient Of Variation | (2,105) | |||
Standard Deviation | 2.41 | |||
Variance | 5.81 | |||
Information Ratio | (0.01) | |||
Jensen Alpha | (0.10) | |||
Total Risk Alpha | 0.125 | |||
Treynor Ratio | (0.49) | |||
Maximum Drawdown | 9.55 | |||
Value At Risk | (3.62) | |||
Potential Upside | 3.6 | |||
Skewness | 0.057 | |||
Kurtosis | (0.34) |
Risk Adjusted Performance | (0.04) | |||
Market Risk Adjusted Performance | (0.48) | |||
Mean Deviation | 1.92 | |||
Coefficient Of Variation | (2,105) | |||
Standard Deviation | 2.41 | |||
Variance | 5.81 | |||
Information Ratio | (0.01) | |||
Jensen Alpha | (0.10) | |||
Total Risk Alpha | 0.125 | |||
Treynor Ratio | (0.49) | |||
Maximum Drawdown | 9.55 | |||
Value At Risk | (3.62) | |||
Potential Upside | 3.6 | |||
Skewness | 0.057 | |||
Kurtosis | (0.34) |
Consider Daxor's intraday indicators
Daxor intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Daxor stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Daxor Corporate Filings
14th of March 2025 Other Reports | ViewVerify | |
F4 | 11th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
3rd of March 2025 Other Reports | ViewVerify | |
10th of September 2024 Other Reports | ViewVerify |
Daxor Stock media impact
Far too much social signal, news, headlines, and media speculation about Daxor that are available to investors today. That information is available publicly through Daxor media outlets and privately through word of mouth or via Daxor internal channels. However, regardless of the origin, that massive amount of Daxor data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Daxor news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Daxor relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Daxor's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Daxor alpha.
Daxor Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Daxor can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Daxor Corporate Directors
James Lombard | Independent Director | Profile | |
Bernhard Saxe | Independent Director | Profile | |
Robert Willens | Independent Director | Profile | |
Jonathan Feldschuh | Chief Scientific Officer, Director | Profile |
Additional Tools for Daxor Stock Analysis
When running Daxor's price analysis, check to measure Daxor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daxor is operating at the current time. Most of Daxor's value examination focuses on studying past and present price action to predict the probability of Daxor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daxor's price. Additionally, you may evaluate how the addition of Daxor to your portfolios can decrease your overall portfolio volatility.